4.3 Article

Assessing the Impact of the NIH CTSA Program on Clinical Trials Registered With ClinicalTrials.gov

Journal

CTS-CLINICAL AND TRANSLATIONAL SCIENCE
Volume 13, Issue 4, Pages 818-825

Publisher

WILEY
DOI: 10.1111/cts.12775

Keywords

-

Ask authors/readers for more resources

Since 2006, the US Congress has appropriated similar to 7 billion dollars in total toward the (CTSA) program of the National Institutes of Health (NIH), representing similar to 1.5% of the NIH total budget. There is no doubt this investment has led to substantial improvements in clinical and translational research, but the impact of these large NIH-sponsored awards to academic medical centers have largely been documented by anecdotal accomplishments. This paper provides a purely quantitative assessment of the impact of these awards on clinical trials registered on . In particular, we find a dramatic increase in the number of registered clinical trials and clinical trial enrollment associated with the CTSA grant award. Additionally, the impact is shown to be magnified with the number of years of receiving CTSA funding.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available